Empowered Funds, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Empowered Funds, LLC

$6.17 Billion
Q3 2024

A detailed history of Empowered Funds, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Empowered Funds, LLC holds 1,652 shares of REGN stock, worth $1.16 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,652

Previous 1,543 7.06%

Holding current value

$1.16 Million

Previous $1.62 Million 7.09%

% of portfolio

0.03%

Previous 0.03%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$1024.09 - $1201.76 $111,625 - $130,991	109 Added 7.06%	1,652 $1.74 Million
Q2 2024 Jul 30, 2024	BUY	$883.2 - $1071.19 $167,808 - $203,526	190 Added 14.04%	1,543 $1.62 Million
Q1 2024 May 06, 2024	BUY	$902.69 - $993.35 $424,264 - $466,874	470 Added 53.23%	1,353 $1.3 Million
Q3 2023 Nov 01, 2023	BUY	$692.45 - $844.37 $130,873 - $159,585	189 Added 27.23%	883 $726,000
Q2 2023 Jul 27, 2023	BUY	$700.03 - $830.35 $170,107 - $201,775	243 Added 53.88%	694 $498,000
Q1 2023 Apr 05, 2023	BUY	$680.49 - $826.97 $46,953 - $57,060	69 Added 18.06%	451 $370,000
Q4 2022 Jan 26, 2023	BUY	$705.89 - $766.39 $269,649 - $292,760	382 New	382 $275,000
Q2 2022 Aug 01, 2022	BUY	$548.35 - $738.84 $241,274 - $325,089	440 Added 6.7%	7,006 $4.14 Million
Q1 2022 Apr 21, 2022	SELL	$595.12 - $698.43 $617,734 - $724,970	-1,038 Reduced 13.65%	6,566 $4.59 Million
Q4 2021 Feb 10, 2022	BUY	$543.48 - $670.97 $4.13 Million - $5.1 Million	7,604 New	7,604 $4.8 Million
Q3 2020 Oct 26, 2020	SELL	$544.75 - $658.21 $1.24 Million - $1.49 Million	-2,268 Closed	0 $0
Q2 2020 Jul 16, 2020	BUY	$493.32 - $643.92 $1.12 Million - $1.46 Million	2,268 New	2,268 $1.41 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Empowered Funds, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empowered Funds, LLC with notifications on news.

Account

Empowered Funds, LLC Regeneron Pharmaceuticals, Inc. Transaction History